Actinogen Medical

Actinogen Medical EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Actinogen Medical (ACW.AX) as of Oct 17, 2026 is -7.06. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -16.23 — a change of -56.52% (higher).

EV/OCF

-7.06

YoY

-56.52%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Actinogen Medical is 2026 -7.06 . EV/OCF (Enterprise Value to Operating Cash Flow) of Actinogen Medical was 2025 -16.23 . It decreases by -56.52% higher compared to the previous year.

The Actinogen Medical EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2019
-12.25 AUD
Jan 1, 2020
-45.95 AUD
Jan 1, 2021
-71.17 AUD
Jan 1, 2022
-12.57 AUD
Jan 1, 2023
-14.66 AUD
Jan 1, 2024
-7.48 AUD
Jan 1, 2025
-16.23 AUD
Jan 1, 2026
-7.06 AUD
The Actinogen Medical EV/OCF history
YEAREV/OCFYoY
-7.06-56.52%
-16.23+117.07%
-7.48-48.99%
-14.66+16.58%
-12.57-82.33%
-71.17+54.87%
-45.95+275.06%
-12.25-23.06%
-15.92-86.82%
-120.83+350.63%
-26.81-20.88%
-33.89-88.99%
-307.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Actinogen Medical Stock analysis

What does Actinogen Medical do? Actinogen Medical Ltd, based in Sydney, Australia, is a clinical-stage biotechnology company operating in the Health Care sector. It focuses on developing novel treatments for cognitive impairment linked to neurological, psychiatric, and metabolic diseases caused by elevated cortisol levels. The company's lead compound, Xanamem, targets the 11B-HSD1 enzyme in the brain to reduce cortisol, with ongoing Phase II studies for Alzheimer’s Disease, Major Depressive Disorder, and Fragile X Syndrome. The firm has conducted research involving approximately 300 volunteers and patients. Actinogen Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Actinogen Medical stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Actinogen Medical is -7.06 in 2026.

EV/OCF (Enterprise Value to Operating Cash Flow) of Actinogen Medical changed from -16.23 to -7.06, representing a -56.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Actinogen Medical since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Actinogen Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Actinogen Medical

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Actinogen Medical